4 Center for Outcomes Research, Saint Louis University School of Medicine, St. Louis, Missouri, USA. Supplementary Material. This supplementary material ...
Pharmacoeconomics 2008; 26 (11): Supplementary Material
Economic Impact and Long-Term Graft Outcomes of Mycophenolate Mofetil Dosage Modifications Following Gastrointestinal Complications in Renal Transplant Recipients Gerardo Machnicki,1 Jean-Francois Ricci,2 Daniel C. Brennan3 and Mark A. Schnitzler4 1 2 3 4
Novartis Pharmaceuticals, East Hanover, New Jersey, USA Novartis Pharma AG, Basel, Switzerland Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA Center for Outcomes Research, Saint Louis University School of Medicine, St. Louis, Missouri, USA
Supplementary Material This supplementary material contains the information referred to in the full version of this article, which can be found at http://pharmacoeconomics.adisonline.com
1
Table AI:
Baseline characteristics at time of first diagnosis of gastrointestinal
complications according to maximum subsequent reduction in MMF dose (NC, no modification to MMF dose; DR, MMF dose reduction; DC, MMF discontinued.) Figures in parentheses indicate percentage of patients in each group. Variable
